KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Total Non-Current Liabilities (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $47.0 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Total Non-Current Liabilities fell 0.71% year-over-year to $47.0 billion, compared with a TTM value of $47.0 billion through Sep 2024, down 0.71%, and an annual FY2023 reading of $47.4 billion, down 3.12% over the prior year.
  • Total Non-Current Liabilities was $47.0 billion for Q3 2024 at Thermo Fisher Scientific, up from $46.7 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $49.7 billion in Q4 2021 and bottomed at $26.9 billion in Q1 2020.
  • Average Total Non-Current Liabilities over 5 years is $40.1 billion, with a median of $46.3 billion recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities surged 81318.18% in 2020, then fell 3.94% in 2021.
  • Year by year, Total Non-Current Liabilities stood at $31.2 billion in 2020, then skyrocketed by 59.36% to $49.7 billion in 2021, then dropped by 1.7% to $48.9 billion in 2022, then fell by 3.12% to $47.4 billion in 2023, then fell by 0.66% to $47.0 billion in 2024.
  • Business Quant data shows Total Non-Current Liabilities for TMO at $47.0 billion in Q3 2024, $46.7 billion in Q2 2024, and $47.0 billion in Q1 2024.